Journal of Research in Pharmaceutical and Allied Sciences consent to receivean illuminated manuscript prepared following the strict requirements mentioned by the Higher Education Commission (HEC).
We only accept manuscript that is not previously submitted or published elsewhere. The context of the submitted manuscript is scam if the context is found at any other source or published in any other journal. It may face disciplinary consequences by being reported to the Higher Education Commission, Pharmacy Council of Pakistan & Pakistan Medical and Dental Council. All data submitted for publication should be sent completely to the Journal of Research in Pharmaceutical & Allied Sciences. Delve back into previously published data for fresh insights is not just acceptable it’s an exciting prospect.
The corresponding manuscript author must submit manuscripts and should not be submitted by anyone on his behalf. When you successfully submit your manuscript electronically, keep an eye on your inbox. You’ll receive a confirmation email acknowledging your submission, addressed to the principal or corresponding author. It’s an essential step on your publishing journey.
To ensure a smooth publication process, it’s essential to submit a complete Information of corresponding author, consent form of authors, and author-declaration form. The completed and signed documents need to be sent back to the journal’s office right away. The processing and publication of the manuscript will be delayed if the forms are not submitted on time.
Any queries there in should be addressed directly via Email : jrpas.jcp@sohailuniveristy.edu.pk OR journal@sohailuniversity.edu.pk
Preferably, the corresponding author has a medical degree, M.Phil., Ph.D., or other pertinent medical qualification. Additionally, the Journal of Research in Pharmaceutical and Allied Sciences only permits one author to serve as a corresponding author.
The order and list of authors, their designations, affiliations, email address must be provided by the corresponding author. Persistent digital identifiers (such as ResearcherID or ORCID) or links to institutional profiles must be provided to specify the identity and affiliation of authors on the manuscript at the time of submission. Make sure the author names are in the right order.
A single institution or discipline study may only have six authors. The Editorial Board will provide guidance on an individual case basis in a multi-institution, multi-disciplinary, and international partnership study.
Only individuals w legitimately involved in the study and accepted public accountability should be granted authorship credit. Significant input into the paper’s idea and data collection, designing, analysis, and interpretation, article drafting, critical revision, and final approval of the version to be published. Anyone identified as an author should be eligible for authorship, and anyone who meets the requirements should be mentioned.
A minimum of two personnel with the necessary topic expertise must be invited by the submitting author to review the manuscript. Every reviewer suggested by an author is thoroughly examined by JRPAS editorial staff, with an emphasis on pertinent scientific competence, before a review invitation is sent.
For analysis, if applicable, the managing editor & assistant editor review each submitted work. They check for plagiarism and review and verify the sources. After undergoing preliminary evaluation, the manuscript is forwarded to the journal’s editors and external reviewers. The essay takes 3-6 weeks to publish once it is first submitted.
Following the initial submission requirements, we evaluate manuscripts using a double-blind peer review procedure. The editors reserve the right to make changes to the accepted paper, but they do not act as peer reviewers for the journal.
A review article, a case report, a brief communication, a student’s corner/knowledge attitude and practice (KAP) study, a letter to the editor, or an original research study (such as a randomized controlled trial (RCT), quasi-experimental study, case-control study, cohort study, observational study with statistical support, meta-analysis, etc, could be the format of the material submitted for publication.
The Editorial Board evaluates the eligibility of any study five years before the submission date because the study topic field changes with time. In rare circumstances, an article may be examined in accordance with the Editorial Board’s opinion that data is significant.
A cover letter that includes the following information:
The title page should carry:
Authors are advised to write manuscripts in British English style, in past tense and third person indirect form of narration. Manuscripts containing language inconsistencies will not be published. Authors should seek professional assistance for correction of grammatical, scientific and typographical errors before submission of the revised version of the article for publication.
1. ORIGINAL CATEGORIES
A minimum of 2000 words should be included in an original article, along with tables and figures along with 25–30 references.
The original document, including the title page, table, and references, should not be more than 3000 words.
Additionally, all randomized trials must demonstrate that they are registered with the International RCT Registry.
A structured abstract of 250 words is required for original articles. Avoid using too many acronyms and avoid referencing sources in the abstract. The abstract must include the following separate sections:
The study’s background, objectives, a synopsis of recent research, and justification should all be covered in this part. Using only strictly relevant references, the section should emphasize the article’s goal. In this section, it is best to avoid citing more than 10-15 sources.
The sample process for the study (patients or lab animals, including controls) should be explained in this section. The name of your organization’s ethical review committee should be explicitly stated along with the age, sex, and other pertinent details. The techniques should be described in enough detail for other workers to perform the procedure, including references, equipment (the name and address of the maker should be enclosed), and procedures. Furthermore, it is necessary to specify the statistical techniques that were employed to examine the data.
The particular test performed for statistical analysis should be identified, ideally with a reference for an uncommon test. It is necessary to include precise p-values and 95% CI limits. Every percentage needs to be supported by actual numbers.
The study’s outcomes should be included in this part, with special attention paid to noteworthy observations and conclusions. Text, tables (each table including a title and footnotes), and legends for pictures and photographs are all possible formats for statistical analysis data. Text documents should be separated by tables. Two to four tables or illustrations should be included.
Only the novel and significant features of the research should be emphasized in this section. Data redundancy and repetition should be avoided. The most recent pertinent research should be cited when discussing the conclusions drawn from the findings, their limitations, and any implications for further study.
This should clearly outline the key findings and explain the significance and applicability of the research to the field. The study’s goals should be aligned with the conclusions.
If there are any abbreviations used in the text, they should be specified at the beginning and a list of them should be given at the end.
The following sections must be included in all manuscripts under the “Declarations” heading:
Please include the headline and indicate “Not applicable” for any sections that are not pertinent to your manuscript.
Provide details of acknowledgement of anyone who supported in the study but did not fit the authorship requirements.
Any conflicts of interest should be declared by each author. Examples of this include grants or honoraria, memberships, credits and promotions, and any other connections that may appear to affect the work. While not immoral, such conflicting interests ought to be disclosed.
Authors should use this heading and put “none to declare” even if there are no conflicts of interest. Or “No conflicts of interest were disclosed by the authors.”
Manuscripts reporting research involving human participants, information should be mentioned.
If appropriate, include the study’s reference number, name of the ethical commission that gave its permission, and a consent and ethics approval statement.
An ethics approval statement is required for studies using animals.
If your article does not involve the use of any animal or human data or tissue, please mention “Not applicable” in the dialogue box.
Any business or organization that has made a financial contribution to the study needs to be recognized.
If applicable, the authors must declare that the patient’s or guardian’s agreement was obtained before the manuscript was written.
This section should list each author’s unique contributions to the manuscript.
To indicate each author’s involvement in this section, please use their initials.
More than 50–70% of the references should be from the previous ten years from the submission date, using the Vancouver reference style. There should be 20-30 references listed.
A few instances of references specified in the Vancouver Style are shown below.
Trease and Evans’ Pharmacognosy. Volatile oils and Resins. Edition 16: William Charles Evans;2009
Riffen burgh RH. Statistics in medicine. 2nd ed. Amsterdam: Elsevier; c2006. Chapter 24, Regression and correlation methods; p. 447-86.
Stohs SJ, Hartman MJ. Review of the safety and efficacy of Moringa oleifera. Phytotherapy Research. 2015 Jun;29(6):796-804. doi.org/10.1002/ptr.5325
Lalau JD, Arnouts P, Sharif A, De Broe ME. Metformin and other antidiabetic agents in renal failure patients. Kidney Int [Internet]. 2015 [cited 2018 Aug 6];87(2):308-22.
Availablefrom: https://www.sciencedirect.com/science/article/pii/S0085253815300429?via%3Dihub
Citations for articles/material published exclusively online or in open access (free-to-view), must contain the accurate Web addresses (URLs) at the end of the reference(s), except those posted on an author’s Web site (unless editorially essential), e.g. ‘Reference: Available from URL’.
AMELIORATIVE EFFECT OF MANGIFERA INDICA LEAVES ON STREPTOZOTOCIN INDUCED TYPE II DIABETES IN MALE ALBINO (WISTAR) RAT MODEL: ROLE OF ANTIDIABETIC AND ANTIOXIDANT EFFECTS
https://www.jptcp.com/index.php/jptcp/article/view/3537
Here are some crucial things to keep in mind:
The Editorial Board may request that writers produce full-length hard copies or soft copies of all the papers referenced in the manuscript’s reference section.
An unstructured abstract (200 words), introduction (200 words), and discussion (up to 2000 words) should all be included in a review, along with 40–60 references. Provide a table, flow chart, or diagram as well for a more thorough explanation of the data.
The journal’s reviews feature may contain, but is not restricted to, the following kinds of articles:
The abstract should be unstructured and no more than 200 words long. Please avoid citing sources in the abstract and use as few abbreviations as possible. Write about the search method, such as which search engines are used to retrieve the data and how many years’ worth of data are used in the analysis.
Three to ten keywords representing the main content of the article should be included.
The introduction section should explain the background to the article, its aims, a summary of a search of the existing literature and the issue under discussion.
This should contain the body of the article and may also be broken into subsections with short and informative headings.
This should clearly outline the key findings and provide a justification for their applicability or significance to the field
A list of abbreviations should be included, and if they are used throughout the text, they should be clarified at the outset.
This section should include the Vancouver reference style and the most recent references (within the previous ten years). It is recommended to cite 40–60 sources.
Case reports might include brief summaries of clinical experiences, medication trials, side effects, and cases. A maximum of 2000 words, ten to fifteen references, one table, and two illustrations should be included. It must provide information that is truly novel.
Title, Abstract, Introduction, Case Presentation, Discussion, and References should all be included in its format. Literature reviews shouldn’t be included in case reports.
There should be no more than 150 words in the unstructured abstract. Please avoid citing sources in the abstract and use as few abbreviations as possible.
The article’s primary content is represented by three to ten keywords from the content.
The context of the case report or research, its objectives, and an overview of the body of existing literature should all be covered in this section.
The patient’s pertinent demographic information, medical history, symptoms, signs, pathology test and other investigation results, treatment or intervention, results, and any other noteworthy information should all be described in this part.
Present findings and differences or similarities with other work done in the field by other workers should be the main topics of discussion. Throughout in depth information shouldn’t be reiterated throughout the conversation. Highlight the study’s novel and significant findings as well as the inferences drawn from them.
The primary findings should be stated here, along with a justification of their significance or applicability to the field.
A list of abbreviations should be included, and if abbreviations are used in the text, they should be specified at the time of use.
The journal’s Meta-Analyses feature may involve but is not restricted to, the quantitative, scientific synthesis of research findings within the purview of the Journal of Research in Pharmaceutical and Allied Sciences. Authors are required to explicitly credit any published and unpublished work they are building upon.
The manuscript’s abstract must be organized into distinct sections and should not be more than 300 words. For a narrative review, an unstructured abstract is also appropriate.
Three to ten keywords representing the main content of the article should be included.
The Main text should consist of following sections.
This part should be well-written, outlining the need for and intended contributions to the field of a meta-analysis on the subject. The section should conclude with the primary review question or questions and a succinct summary of the findings pertaining to research design, participants, interventions, and outcomes.
All phases of the review process, the review’s design, the location, kind of materials or individuals engaged, and the sort of analysis should all be clearly described. Explain the procedures utilized to evaluate each research’s risk of bias, stating whether this was done at the study or outcome level and how the results were included into any data synthesis. Identifying the methodological standards for the issue of interest should be aided by early discussions with stakeholders and experts.
Data extraction strategy: how did you calculate effect sizes and their variability, and what kind of data do you hope to find or have retrieved in the end?
Data synthesis and presentation: Describe the qualitative and quantitative techniques you employed to combine and display the data, together with any aspects you have detected or anticipated, such as biases, effect modifiers, and the kind of methodologies and their current evaluation.
Examine statistics: The quantity of articles that were discovered during the search and included at every level of inclusion or exclusion, as well as any pertinent details regarding the distribution of the studies that were discovered (such as the study’s location and source). It is necessary to produce a flow diagram that details the inclusion/exclusion procedure while adhering to pertinent reporting criteria, such as PRISMA.
Examine the quality assessment: It is necessary to include a summary of the findings of the many research, the level of confidence in the findings, the biases present in each study, and the overall quality of the various studies.
Meta-analysis/quantitative synthesis (if feasible): If effect sizes for the included studies that measure comparable outcomes can be computed, then a quantitative evaluation of these effect sizes should be conducted. This evaluation should include summary statistics of the mean effect, confidence in the mean, the range of effects, and sources of effect heterogeneity.
Evidence of effectiveness: A thorough analysis of the data provided by the publications regarding the effects of the intervention, the strength of the evidence, and a critical evaluation of the articles. Furthermore, an objective evaluation of the degree of evidence provided by the research is required.
Only recommendations for additional research or analysis, such as possible causes of outcome heterogeneity, including potential effect modifiers and the influence of variation in the study factors like experimental design, should be allowed in the discussion section. Restrictions resulting from the search method and bias in the articles found should typically be discussed in a section on review restrictions. It is also important to draw attention to any gaps in the data that the research has provided.
This should clearly outline the article’s key findings and explain the implications for management and policy. It should also summarize the current state of the evidence base and how much it influences decision-making with regard to the review question and any degree of uncertainty surrounding the result.
If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided.
Vancouver reference style and latest references (last five years) should be specified in this section. A minimum of 25 references should be cited.
All clinical trials that are submitted for publication must be based on the CONSORT statement, be registered in a public registry, and provide proof of registration. Trials that are not registered will not be published. Refer to the original article’s instructions for writing a manuscript.
A 150-word, non-structured abstract with two tables or figures and no more than 15 references are what are required for short communications and commentaries.
The CHS research contributions from students that are based on the KAP study are also accepted. 1000–1500 words of information should adhere to the original article’s overall framework.
Instructions of the original article should be followed.
Letters to Editors should be concise and not exceed 400 words with a maximum of 5 references.
Illustration legends ought to be typed on the same page. Instead of repeating material in the text, tables should be used as a complement; those that do so will be left out.
In the order that they are mentioned in the text, tables should be numbered consecutively. Submissions of graphs, scattergrams, or histograms must include the numerical data that served as their basis.
System International (S.I.) Unit measurement should be used. Imperial measurement units like inches, feet, etc. are not acceptable.
Photographs, X-rays, CT scans, MRIs, and photomicrographs should all be transmitted digitally in JPEG/TIFF compression with a minimum pixel resolution of 3.2. Photographs need to be focused precisely. The majority of photos taken with a mobile phone’s camera don’t meet the requirements and aren’t suitable for printing. Photographs must have a neutral background, ideally white.
The resolution of scanned photos must be 300 dpi or above. The text needs to cite these images and figures in the correct sequence.
To prevent errors, the final document is forwarded to the associated author for a galley proofread before to publishing. Clarity should be maintained while making corrections, and the editor should be notified via email.
There is no publication fee for articles submitted in the Journal of Research in Pharmaceutical and Allied Sciences.
Summarize your business so the visitor can learn about your offerings from any page on your website.
© All Rights Reserved.